SSSuma Mohan Saraswathi

Suma Mohan Saraswathi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Suma Mohan Saraswathi has a total of 119 co-authors. Here are the top co-authors by number of shared publications:

  • Srimathy Ramachandran

    DBT-Bioinformatics Center, School of Chemical & Biotechnology, SASTRA Deemed to be University Thanjavur Tamil Nadu 613401 Shanmugha Arts Science Technology and Research Academy

    8 shared publications
  • Akilandeswari Ramu

    DBT-Bioinformatics Center, School of Chemical & Biotechnology, SASTRA Deemed to be University Thanjavur Tamil Nadu 613401 Shanmugha Arts Science Technology and Research Academy

    3 shared publications
  • Chethala N. Vishnuprasad

    Ayurveda Biology and Holistic Nutrition, The University of Transdisciplinary Health Sciences and Technology (TDU), No.74/2, Jarakabande Kaval Post: Attur, Via Yelahanka, Bengaluru – 560-064, Karnataka, India

    3 shared publications
  • Gopalakrishnapillai Anilkumar

    Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam, India

    3 shared publications
  • Saisubramanian Nagarajan

    Antimicrobial Resistance Lab, Centre for Research in Infectious Diseases, School of Chemical and Biotechnology, SASTRA Deemed to be University, Thanjavur, India

    3 shared publications
  • Sasikala Rajendran

    DBT-Bioinformatics Center, School of Chemical & Biotechnology, SASTRA Deemed to be University Thanjavur Tamil Nadu 613401 Shanmugha Arts Science Technology and Research Academy

    3 shared publications

Latest Publications

  • Open Access

    Exploring the evolution of multidrug resistance patterns in ESKAPEE pathogens using association mining: Key to antibiotic stewardship?

    by Sasikala Rajendran, Srimathy Ramachandran, Akilandeswari Ramu, Yashwenth S, Surya Murugan, Vigneshwar Ramakrishnan, Suma Mohan S

    Background Shared Multidrug resistance (sMDR) is a major challenge in antimicrobial therapy, particularly among ESKAPEE pathogens, as these bacteria develop resistance to multiple antimicrobial agents via mutations, recombination, or gene transfer. These antimicrobial resistance (AMR) mechanisms evolve and require constant surveillance. Understanding sMDR patterns in large antimicrobial surveillance datasets is complex because of the multifaceted nature of the data. Methods We explored Pfizer-Atlas (2004 – 2022) and Venatorx-GEARS (2018-2022) datasets from the Vivli platform, focusing on ESKAPEE pathogens. Descriptive data analysis, time-trend analysis, and association rule generation through the Apriori algorithm were performed using Python 3.10 libraries pandas, matplotlib, seaborn, scipy.stats, and mlxtend libraries. The best rule set that explored sMDR patterns was visualized in a network format using NetworkX: 3.2 package. Results “MERIT- Multidrug ESKAPEE Resistance Insights and Tracker” dashboard was created for user-friendly visualization of antimicrobial surveillance datasets, trends in antimicrobial susceptibility profile (ASP) over years, interactive widgets to see the ASP by country and by pathogens, and Network to see significant rules as a result of association rule mining in categories by age, year and country. Conclusion Time trend analysis revealed a decline in meropenem and piperacillin-tazobactam resistance to Enterococcus faecium and doripenem for Pseudomonas aeruginosa , while resistance to imipenem ( Klebsiella pneumoniae , Acinetobacter baumannii , and Enterobacter species) and meropenem ( Staphylococcus aureus , A. baumannii , and Enterobacter species) increased. Association rule mining identified sMDR patterns, such as meropenem and levofloxacin resistance, in S. aureus , K. pneumoniae , P. aeruginosa and A. baumannii. Thus, our findings from the data challenge represents hypothesis driven patterns intended to promote further investigation and clinical validation which potentially supports antibiotic stewardship efforts.

  • Open Access

    The systemic anti-diabetic effect of polyherbal formulation Varanadi Kashayam is mediated through GLP-1 secretion and DPP4 inhibition

    by Anjana Thottappillil, Sania Kouser, Abhi V. Badiger, Priyanka Gladys Pinto, Srimathy Ramachandran, Suresh Janadri, Manjunatha P. Mudagal, Subrahmanya Kumar Kukkupuni, S. Suma Mohan, Chethala N. Vishnuprasad

  • Open Access

    Integrated Machine Learning-PanGWAS Reveals Chromosome-Encoded Persistence Networks and Plasmid Plasticity in Recurrent Urinary Tract Infection in Escherichia coli

    by Sasikala R, Saisubramanian Nagarajan, Suma Mohan S.

    Background: Recurrent urinary tract infections(rUTI) represent a major clinical challenge due to persistent clinical symptoms, repeated antibiotic exposure, and increased risk of multidrug resistance. Further clinical management of rUTI remains challenging, as existing diagnostic and treatment guidelines are largely designed for uncomplicated, acute infections. Though uropathogenic Escherichia coli (UPEC) is the predominant cause of community-acquired UTIs, pathogen-derived genomic features that may predispose certain E. coli strains to repeatedly establish infection are not fully understood. Methods: To comprehensively dissect distinct genetic signals across genomic compartments that distinguish rUTI-associated isolates from those causing sporadic infection, the pangenome analysis in three different frameworks (i) Combined genomes (chromosome + plasmid), (ii) bacterial chromosomes only and (iii) plasmid-only was conducted. A comprehensive evaluation of population structure was performed using Gubbins, recombination-aware phylogeny IQTree, phylogroup distribution, pan-genome openness using Heap’s law, and plasmidome architecture using MOBSUITE. Findings: Supervised machine learning models showed that the highest discriminatory performance was achieved using the combined genomic dataset (accuracy ∼0.98), and integration of feature-selected genes with PanGWAS (Pyseer and Scoary) identified a robust set of recurrence-associated genes, namely cbtA, cbeA , and ldrD , which were consistently detected across machine learning and association frameworks. Subsequent association rule mining further revealed cooperative gene networks enriched in rUTI isolates, particularly involving toxin-antitoxin modules and metabolic regulators. Interpretation: Overall, this integrated ML-PanGWAS approach demonstrates that rUTI is a lineage-independent, polygenic phenotype encoded within a combined chromosomal-plasmid genomic context, providing new insights into the bacterial genomic architecture underlying recurrent disease and offering candidate biomarkers for future diagnostic and therapeutic development. Funding: The Department of Biotechnology (DBT), Government of India (grant numbers: BT/PR40150/BTIS/137/81/2023 and the SASTRA TRR grant (SASTRA TRR SCBT OCT-23). Evidence before this study: We searched PubMed, Scopus, and Web of Science for studies published from database inception to March 2026, without language restrictions, using combinations of the terms “recurrent urinary tract infection”, “uropathogenic Escherichia coli ”, “pan-genome”, “genome-wide association”, “plasmid”, and “machine learning”. We included studies investigating genomic, phylogenetic, or functional differences between recurrent and sporadic UTI isolates. Previous studies have primarily used phylogenetic and single nucleotide polymorphism (SNP)-based approaches and reported limited genomic differentiation, with no consistent clustering or robust gene-level associations. Overall, existing evidence is heterogeneous and largely limited to single-layer genomic analyses. Added value of this study: This study integrates pan-genome analysis across chromosomal, plasmid, and combined datasets with machine learning, genome-wide association analysis, and association rule mining. In contrast to previous SNP-based studies, we show that recurrent UTI isolates can be robustly discriminated only when chromosomal and plasmid features are analysed jointly. We identify reproducible recurrence-associated genes, including cbtA, cbeA , and klcA , and demonstrate that these genes form cooperative networks involving persistence, plasmid-mediated transfer, and metabolic adaptation, supporting a polygenic basis of recurrence. Implications of all the available evidence: Our findings indicate that recurrent UTI is not driven by lineage alone but by coordinated accessory gene networks spanning chromosomal and plasmid compartments. Although certain sequence types are more frequently associated with recurrence, they are not exclusive and likely serve as backgrounds for enriched gene modules. These results highlight the importance of integrated genomic profiling for predicting recurrence risk and identifying persistence and adaptation pathways as potential targets for future diagnostic and therapeutic strategies.


  • Open Access

    Exploring the evolution of multidrug resistance patterns in ESKAPEE pathogens using association mining: Key to antibiotic stewardship?

    by Sasikala Rajendran, Srimathy Ramachandran, Akilandeswari Ramu, Yashwenth S, Surya Murugan, Vigneshwar Ramakrishnan, Suma Mohan S

    Background Shared Multidrug resistance (sMDR) is a major challenge in antimicrobial therapy, particularly among ESKAPEE pathogens, as these bacteria develop resistance to multiple antimicrobial agents via mutations, recombination, or gene transfer. These antimicrobial resistance (AMR) mechanisms evolve and require constant surveillance. Understanding sMDR patterns in large antimicrobial surveillance datasets is complex because of the multifaceted nature of the data. Methods We explored Pfizer-Atlas (2004 – 2022) and Venatorx-GEARS (2018-2022) datasets from the Vivli platform, focusing on ESKAPEE pathogens. Descriptive data analysis, time-trend analysis, and association rule generation through the Apriori algorithm were performed using Python 3.10 libraries pandas, matplotlib, seaborn, scipy.stats, and mlxtend libraries. The best rule set that explored sMDR patterns was visualized in a network format using NetworkX: 3.2 package. Results “MERIT- Multidrug ESKAPEE Resistance Insights and Tracker” dashboard was created for user-friendly visualization of antimicrobial surveillance datasets, trends in antimicrobial susceptibility profile (ASP) over years, interactive widgets to see the ASP by country and by pathogens, and Network to see significant rules as a result of association rule mining in categories by age, year and country. Conclusion Time trend analysis revealed a decline in meropenem and piperacillin-tazobactam resistance to Enterococcus faecium and doripenem for Pseudomonas aeruginosa , while resistance to imipenem ( Klebsiella pneumoniae , Acinetobacter baumannii , and Enterobacter species) and meropenem ( Staphylococcus aureus , A. baumannii , and Enterobacter species) increased. Association rule mining identified sMDR patterns, such as meropenem and levofloxacin resistance, in S. aureus , K. pneumoniae , P. aeruginosa and A. baumannii. Thus, our findings from the data challenge could aid healthcare professionals in making informed decisions regarding antibiotic use.

  • Open Access

    Unveiling meropenem resistance and co-resistance patterns in Klebsiella pneumoniae and Acinetobacter baumannii: a global genome analysis using ML/DL and association mining

    by Srimathy Ramachandran, Deepak K, Shrikumaran M, Mohamed Rasiq R, Ananya S, Aruna V, Derrick Daniel P, Sruthi B, Suma Mohan S

    The increasing prevalence of meropenem-resistant gram-negative bacteria has led to higher treatment failure and mortality rates. The global availability of bacterial WGS data with antimicrobial resistance phenotypes enables large-scale analyses to explore resistance determinants. This study investigated meropenem resistance mechanisms in multidrug-resistant Klebsiella pneumoniae (KP) and Acinetobacter baumannii (AB) isolates using advanced data analytics. We analysed AMR genes and mutations from 2,411 KP and 375 AB isolates. Notable differences were observed in the proportions of genes contributing to the meropenem resistance mechanism categories between KP and AB, including carbapenemases (4% in KP, 23% in AB), antibiotic efflux (30%, 60%), target alteration (23%, 12%), and reduced permeability (18%, 3%). Mutation frequencies also varied, with antibiotic efflux (26%, 67%), target alteration (64%, 5%), and reduced permeability (7%, 15%). Using ML/DL and association mining approaches, we identified key features such as blaKPC−2, blaKPC−3, bleMBL, and aac(6’)-Ib9 in KP, and blaOXA−23, Abau_gyrA_FLO|Ser81Leu, and Abau_OprD_IMP|Asn411Asp in AB. The co-occurrences of AAC genes and gyrA mutation suggest co-resistance to meropenem, aminoglycosides, and fluoroquinolones, while oprD mutations may indicate a shared resistance potential. These results offer additional insights into the complexity of meropenem resistance and its associated factors.


  • Open Access

    Exploring the evolution of multidrug resistance patterns in ESKAPEE pathogens using association mining: Key to antibiotic stewardship?

    by Sasikala Rajendran, Srimathy Ramachandran, Akilandeswari Ramu, Yashwenth S, Surya Murugan, Vigneshwar Ramakrishnan, Suma Mohan S

    Background Shared Multidrug resistance (sMDR) is a major challenge in antimicrobial therapy, particularly among ESKAPEE pathogens, as these bacteria develop resistance to multiple antimicrobial agents via mutations, recombination, or gene transfer. These antimicrobial resistance (AMR) mechanisms evolve and require constant surveillance. Understanding sMDR patterns in large antimicrobial surveillance datasets is complex because of the multifaceted nature of the data. Methods We explored Pfizer-Atlas (2004 – 2022) and Venatorx-GEARS (2018-2022) datasets from the Vivli platform, focusing on ESKAPEE pathogens. Descriptive data analysis, time-trend analysis, and association rule generation through the a priori algorithm were performed using Python 3.10 libraries pandas, matplotlib, seaborn, scipy.stats, and mlxtend libraries. The best rule set that explored sMDR patterns was visualized in a network format using NetworkX: 3.2 package. Results “MERIT- Multidrug ESKAPEE Resistance Insights and Tracker” dashboard was created for user-friendly visualization of antimicrobial surveillance datasets, trends in antimicrobial susceptibility profile (ASP) over years, interactive widgets to see the ASP by country and by pathogens, and Network to see significant rules as a result of association rule mining in categories by age, year and country. Conclusion Time trend analysis revealed a decline in meropenem and piperacillin-tazobactam resistance to Enterococcus faecium and doripenem for Pseudomonas aeruginosa , while resistance to imipenem ( Klebsiella pneumoniae , Acinetobacter baumannii , and Enterobacter species) and meropenem ( Staphylococcus aureus , A. baumannii , and Enterobacter species) increased. Association rule mining identified sMDR patterns, such as meropenem and levofloxacin resistance, in S. aureus , K. pneumoniae , P. aeruginosa and A. baumannii . Thus, our findings from the data challenge could aid healthcare professionals in making informed decisions regarding antibiotic use.

  • Open Access

    Unveiling Meropenem Resistance and Co-Resistance Patterns in Klebsiella pneumoniae and Acinetobacter baumannii : A Global Genome Analysis Using ML/DL and Association Mining

    by Srimathy Ramachandran, K Deepak, M Shrikumaran, R Mohamed Rasiq, S Ananya, V Aruna, P Derrick Daniel, B Sruthi, Mohan S Suma

    Background: The increasing prevalence of meropenem-resistant gram-negative bacteria has significantly undermined its effectiveness and has increased treatment failure and mortality rates. The global availability of bacterial WGS data with antimicrobial resistance phenotypes enables large-scale genome analysis to explore resistance determinants. This study investigated the meropenem resistance mechanism in multidrug-resistant (MDR) Klebsiella pneumoniae (KP) and Acinetobacter baumannii (AB) isolates using advanced data analytics approaches. Methods: We analysed 2,411 KP and 375 AB isolates with meropenem-resistant and susceptible phenotypes from the BV-BRC database. AMR genes and mutations were identified from the isolates using the CARD database as a reference. Significant AMR genes and missense mutations, determined through chi-square tests, were subsequently used to train ML and DL models. The best-performing SVM model was used for sequential feature selection to identify key features. Additionally, association mining was conducted separately on the selected features and the antibiotics data. Results: Notable differences were observed in the proportions of genes contributing to the meropenem resistance mechanism categories between KP and AB, including carbapenemases (4% in KP, 23% in AB), antibiotic efflux (30%, 60%), target alteration (23%, 12%), and reduced permeability (18%, 3%). Mutation frequencies also vary, with antibiotic efflux (26%, 67%), target alteration (64%, 5%), and reduced permeability (7%, 15%). A total of 410 significant features in KP and 211 in AB were identified for model building. SVM-based feature selection pinpointed seven key features in KP and 10 in AB, resulting in 95% accuracy for both. Association mining revealed bla KPC-2 , bla KPC-3 , ble MBL , and aac(6’)-Ib9 as key factors in KP, and bla OXA-23 , Abau_gyrA_FLO|Ser81Leu, and Abau_OprD_IMP|Asn411Asp in AB associated with meropenem resistance. The observed prevalence of AAC genes and the gyrA mutation, along with insights from association mining, reveals the co-resistance of meropenem with aminoglycosides and fluoroquinolones, while oprD mutations imply potential shared resistance across antibiotics. Conclusion: The analysis of AMR genes and mutations based on resistance mechanisms revealed distinct differences in meropenem resistance between KP and AB. The ML/DL models and association mining approaches identified key resistance features and cross-antibiotic resistance insights. These findings deepen our understanding of meropenem resistance, enabling more precise and effective antimicrobial interventions.